Importantly, the CLL-specific SPIB1, BCLAF1, and SMARCB1 were identified as putative TFs activating HRK and PMAIP1 expression in the CLL phase (Fig. 5F). This evidence concerns the gene BCLAF1 and B-cell chronic lymphocytic leukemia.